Covid-19 rebound is probably more common than data suggests, but Paxlovid is still effective

As the coronavirus evolves, the number of treatment options that remain effective against new variants has dwindled. Pfizer's antiviral pill Paxlovid is one of the few that remain. However, some people who take Paxlovid -- and some who don't -- experience a rebound case of Covid-19, with a resurgence of symptoms...

Read more...

Many patients stop taking statins because of muscle pain, but statins aren’t causing it, new study says

Statins are an important tool to prevent major cardiovascular problems, but many patients stop taking them because of side effects, including muscle pain. However, for more than 90% of patients on statins who experience muscle pain, the statin is not the cause of the pain, according to a study published Monday in...

Read more...

What to know about bipolar disorder and sex

Bipolar disorder causes a person to experience intense shifts in moods, sometimes from a manic state to a depressed state, for example. These shifts can occur with changes in sexual desire, confidence, or sexual function. Though the symptoms vary from person to person, bipolar disorder can disrupt several aspects of a person’s life,...

Read more...

What is box breathing?

Box breathing is a powerful, yet simple, relaxation technique that aims to return breathing to its normal rhythm. This breathing exercise may help to clear the mind, relax the body, and improve focus. The technique is also known as “resetting your breath” or four-square breathing. It is easy to do, quick...

Read more...

What to know about anxiety

Anxiety is a normal and often healthy emotion. However, when a person regularly feels disproportionate levels of anxiety, it might become a medical disorder. Anxiety disorders form a category of mental health diagnoses that lead to excessive nervousness, fear, apprehension, and worry These disorders alter how a person processes emotions and behave, also causing physical...

Read more...

Atopic dermatitis: FDA approves Dupixent to treat young children

The Food and Drug Administration (FDA) approved Dupixent (dupilumab) to treat atopic dermatitis in children ages 6 months to 5 years old.Dupixent is already approved to treat this skin condition in adults and children ages 6-17.This FDA approval marks the first time the agency greenlighted a biologic medication to treat...

Read more...

Alopecia: FDA approves Olumiant for hair loss treatment

The Food and Drug Administration (FDA) originally approved Olumiant (baricitinib) in 2018 to treat rheumatoid arthritis.The approval of Oluminant reportedly marks the first time the FDA approved a “systemic treatment” for this form of alopecia.Olumiant is available in tablet form and is a daily medication. There are several forms of alopecia, including alopecia areata,...

Read more...

Monkeypox outbreak: What to know

Since early May 2022, many countries in Europe, as well as Australia, and the U.S. have reported an increasing number of monkeypox cases.As a viral disease native to Africa, monkeypox is usually transmitted by animal-to-human contact, producing skin lesions, fever, and body aches in people the virus infects.Some recent cases of...

Read more...

Moderna says its Covid-19 vaccine performs as well in children as it does in adults

Moderna announced interim results of its Covid-19 vaccine for children younger than 6 on Wednesday.The company said two 25-microgram doses of its Covid-19 vaccine for children ages 6 months through 5 years old provided a similar immune response to two 100-microgram doses for adults ages 18 to 25, indicating that...

Read more...

COVID-19 live updates: What do we know about Omicron’s ‘stealth variant’?

A new version of the Omicron variant of SARS-CoV-2, known as BA.2, has emerged. Although experts are unsure about its effects, they know that it is spreading quickly and has 20 mutations in the area that most COVID-19 vaccines target. “Up until now, the overwhelmingly large majority of all Omicron cases...

Read more...